Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Milrinone in Off-Pump CABG
NCT03855579Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Mar 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levosimendan in hemodynamic instability (2 arms), sponsored by Assiut University. Primary endpoints: Mean Arterial Pressure and Consumption of other inotropes. Status: unknown.
02
Drugs
levosimendan
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT03855579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855579.